Digitalis Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Elegenelegenbio.comin𝕏May 2024
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep TechSan Carlos, US
Matthew Hill(Executive Officer, Director)Jonathan Sheena(Director)
BoardPeter Zhou(Director)Cain McClary(Director)
Galatea Biogalatea.bioAug 2024
HealthtechMiami Lakes, US
Carlos D. Bustamante(Executive Officer, Director)Alexander Ioannidis(Director)Arthur Polk(Executive Officer)
BoardWale Ayeni(Director)Mohit Kaushal(Director)Nicholas Katsanis(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.